77
38
Growth Score
-9 pts
Heat Score
-7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
3560782
CanBas is a biopharmaceutical company that researches and develops anti-cancer drugs with fewer side effects.
Takumi Kawabe: President, Board Member & CEO
About the Company
CanBas is a biopharmaceutical company that research and develops anti-cancer drugs. The company develops CBP501 which completes phase II clinical trials for the treatment of malignant pleural mesothelioma and non-small cell lung cancers. It also develops CBS9106, a reversible XPO-1 inhibitor for the treatment of solid tumors.
CanBas is a
Japan-based company that was founded in 2000.
